Report Summary
Eternity Insights has published a new study on Global Asia-Pacific Animal Therapeutics And Diagnostics Market focusing on key segments as by Type (Animal Diagnostics Products, Instruments, Consumables, Animal Therapeutics Products, Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs), by Application (Companion Animals, Dogs, Cats, Other Companion Animals, Cattle, Pigs, Poultry, Sheep), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Asia-Pacific Animal Therapeutics And Diagnostics Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Asia-Pacific Animal Therapeutics And Diagnostics Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Asia-Pacific Animal Therapeutics And Diagnostics Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Asia-Pacific Animal Therapeutics And Diagnostics Market Segmentation:
Asia-Pacific Animal Therapeutics And Diagnostics Market, By Type
- Animal Diagnostics Products
- Instruments
- Consumables
- Animal Therapeutics Products
- Anti-Parasitic Drugs and Antibiotics
- Anti-Inflammatory Drugs
- Anesthetics
- Other Drugs
Asia-Pacific Animal Therapeutics And Diagnostics Market, By Application
- Companion Animals
- Dogs
- Cats
- Other Companion Animals
- Cattle
- Pigs
- Poultry
- Sheep
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Asia-Pacific Animal Therapeutics And Diagnostics market in terms of demand generation. The Asia-Pacific Animal Therapeutics And Diagnostics market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Asia-Pacific Animal Therapeutics And Diagnostics market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Asia-Pacific Animal Therapeutics And Diagnostics Market Taxonomy:
To learn more about this report
Global Asia-Pacific Animal Therapeutics And Diagnostics Market Competitive Landscape
The global Asia-Pacific Animal Therapeutics And Diagnostics market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Bayer
- Eli Lilly and Company
- Boehringer
- Ingelheim
- Merck & Co
- Zoetis
- Ceva Sant� Animale
- Sanofi
- Nutreco
- Virbac
- Abaxis
- Heska
- IDEXX Laboratories
- Novartis Animal Health
- Pfizer Animal Health
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Animal Diagnostics Products, Instruments, Consumables, Animal Therapeutics Products, Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs |
| By Application Outlook |
Companion Animals, Dogs, Cats, Other Companion Animals, Cattle, Pigs, Poultry, Sheep |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Bayer, Eli Lilly and Company, Boehringer, Ingelheim, Merck & Co, Zoetis, Ceva Sant� Animale, Sanofi, Nutreco, Virbac, Abaxis, Heska, IDEXX Laboratories, Novartis Animal Health, Pfizer Animal Health |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Animal Therapeutics and Diagnostics Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Animal Diagnostics Products Market Performance (Volume)
2.1.2 Instruments Market Performance (Volume)
2.1.3 Consumables Market Performance (Volume)
2.1.4 Animal Therapeutics Products Market Performance (Volume)
2.1.5 Anti-Parasitic Drugs and Antibiotics Market Performance (Volume)
2.1.6 Anti-Inflammatory Drugs Market Performance (Volume)
2.1.7 Anesthetics Market Performance (Volume)
2.1.8 Other Drugs Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Animal Diagnostics Products Market Performance (Value)
2.2.2 Instruments Market Performance (Value)
2.2.3 Consumables Market Performance (Value)
2.2.4 Animal Therapeutics Products Market Performance (Value)
2.2.5 Anti-Parasitic Drugs and Antibiotics Market Performance (Value)
2.2.6 Anti-Inflammatory Drugs Market Performance (Value)
2.2.7 Anesthetics Market Performance (Value)
2.2.8 Other Drugs Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Companion Animals Market Performance (Volume)
3.1.2 Dogs Market Performance (Volume)
3.1.3 Cats Market Performance (Volume)
3.1.4 Other Companion Animals Market Performance (Volume)
3.1.5 Cattle Market Performance (Volume)
3.1.6 Pigs Market Performance (Volume)
3.1.7 Poultry Market Performance (Volume)
3.1.8 Sheep Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 Bayer
4.1.1 Bayer Profiles
4.1.2 Bayer Product Information
4.1.3 Bayer Animal Therapeutics and Diagnostics Business Performance
4.1.4 Bayer Animal Therapeutics and Diagnostics Business Development and Market Status
4.2 Eli Lilly and Company
4.2.1 Eli Lilly and Company Profiles
4.2.2 Eli Lilly and Company Product Information
4.2.3 Eli Lilly and Company Animal Therapeutics and Diagnostics Business Performance
4.2.4 Eli Lilly and Company Animal Therapeutics and Diagnostics Business Development and Market Status
4.3 Boehringer
4.3.1 Boehringer Profiles
4.3.2 Boehringer Product Information
4.3.3 Boehringer Animal Therapeutics and Diagnostics Business Performance
4.3.4 Boehringer Animal Therapeutics and Diagnostics Business Development and Market Status
4.4 Ingelheim
4.4.1 Ingelheim Profiles
4.4.2 Ingelheim Product Information
4.4.3 Ingelheim Animal Therapeutics and Diagnostics Business Performance
4.4.4 Ingelheim Animal Therapeutics and Diagnostics Business Development and Market Status
4.5 Merck & Co
4.5.1 Merck & Co Profiles
4.5.2 Merck & Co Product Information
4.5.3 Merck & Co Animal Therapeutics and Diagnostics Business Performance
4.5.4 Merck & Co Animal Therapeutics and Diagnostics Business Development and Market Status
4.6 Zoetis
4.6.1 Zoetis Profiles
4.6.2 Zoetis Product Information
4.6.3 Zoetis Animal Therapeutics and Diagnostics Business Performance
4.6.4 Zoetis Animal Therapeutics and Diagnostics Business Development and Market Status
4.7 Ceva Santé Animale
4.7.1 Ceva Santé Animale Profiles
4.7.2 Ceva Santé Animale Product Information
4.7.3 Ceva Santé Animale Animal Therapeutics and Diagnostics Business Performance
4.7.4 Ceva Santé Animale Animal Therapeutics and Diagnostics Business Development and Market Status
4.8 Sanofi
4.8.1 Sanofi Profiles
4.8.2 Sanofi Product Information
4.8.3 Sanofi Animal Therapeutics and Diagnostics Business Performance
4.8.4 Sanofi Animal Therapeutics and Diagnostics Business Development and Market Status
4.9 Nutreco
4.9.1 Nutreco Profiles
4.9.2 Nutreco Product Information
4.9.3 Nutreco Animal Therapeutics and Diagnostics Business Performance
4.9.4 Nutreco Animal Therapeutics and Diagnostics Business Development and Market Status
4.10 Virbac
4.10.1 Virbac Profiles
4.10.2 Virbac Product Information
4.10.3 Virbac Animal Therapeutics and Diagnostics Business Performance
4.10.4 Virbac Animal Therapeutics and Diagnostics Business Development and Market Status
4.11 Abaxis
4.12 Heska
4.13 IDEXX Laboratories
4.14 Novartis Animal Health
4.15 Pfizer Animal Health
5 Market Performance for Manufacturers
5.1 Asia-Pacific Animal Therapeutics and Diagnostics Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Asia-Pacific Animal Therapeutics and Diagnostics Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Asia-Pacific Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
5.4 Asia-Pacific Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Animal Therapeutics and Diagnostics Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Animal Therapeutics and Diagnostics Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 Japan Market Performance for Manufacturers
6.2.1 Japan Animal Therapeutics and Diagnostics Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 Japan Animal Therapeutics and Diagnostics Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 Japan Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 Japan Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 South Korea Market Performance for Manufacturers
6.3.1 South Korea Animal Therapeutics and Diagnostics Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 South Korea Animal Therapeutics and Diagnostics Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 South Korea Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 South Korea Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 India Market Performance for Manufacturers
6.4.1 India Animal Therapeutics and Diagnostics Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 India Animal Therapeutics and Diagnostics Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 India Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 India Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Southeast Asia Market Performance for Manufacturers
6.5.1 Southeast Asia Animal Therapeutics and Diagnostics Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Southeast Asia Animal Therapeutics and Diagnostics Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Southeast Asia Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Southeast Asia Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Australia Market Performance for Manufacturers
6.6.1 Australia Animal Therapeutics and Diagnostics Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Australia Animal Therapeutics and Diagnostics Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Australia Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Australia Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Market Performance for Manufacturers
6.7.1 Animal Therapeutics and Diagnostics Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Animal Therapeutics and Diagnostics Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Animal Therapeutics and Diagnostics Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 Animal Therapeutics and Diagnostics Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 Animal Therapeutics and Diagnostics Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 Animal Therapeutics and Diagnostics Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Asia-Pacific Animal Therapeutics and Diagnostics Market Performance (Sales)
7.1 Asia-Pacific Animal Therapeutics and Diagnostics Sales (K Units) and Market Share by Regions 2014-2020
7.2 Asia-Pacific Animal Therapeutics and Diagnostics Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Asia-Pacific Animal Therapeutics and Diagnostics Price (USD/Unit) by Regions 2014-2020
7.4 Asia-Pacific Animal Therapeutics and Diagnostics Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales)
8.1 Asia-Pacific Animal Therapeutics and Diagnostics Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 China Animal Therapeutics and Diagnostics Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 Japan Animal Therapeutics and Diagnostics Sales and Growth, Sales Value and Growth Rate 2014-2020
8.4 South Korea Animal Therapeutics and Diagnostics Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 India Animal Therapeutics and Diagnostics Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Southeast Asia Animal Therapeutics and Diagnostics Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 Australia Animal Therapeutics and Diagnostics Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Companion Animals Industry
11.2 Dogs Industry
11.3 Cats Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Asia-Pacific Animal Therapeutics and Diagnostics Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Asia-Pacific Animal Therapeutics and Diagnostics Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Animal Therapeutics and Diagnostics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 Japan Animal Therapeutics and Diagnostics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 South Korea Animal Therapeutics and Diagnostics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 India Animal Therapeutics and Diagnostics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Southeast Asia Animal Therapeutics and Diagnostics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Australia Animal Therapeutics and Diagnostics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Animal Diagnostics Products Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.3 Instruments Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.4 Consumables Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.5 Animal Therapeutics Products Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.6 Anti-Parasitic Drugs and Antibiotics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.7 Anti-Inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.8 Anesthetics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.9 Other Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales and Growth Rate Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Companion Animals
12.3.3 Dogs
12.3.4 Cats
12.3.5 Other Companion Animals
12.3.6 Cattle
12.3.7 Pigs
12.3.8 Poultry
12.3.9 Sheep
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Asia-Pacific Animal Therapeutics and Diagnostics Price (USD/Unit) Trend 2021-2026
12.4.2 Asia-Pacific Animal Therapeutics and Diagnostics Gross Profit Trend 2021-2026
13 Conclusion
